|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4272 USD | -3.87% |
|
+6.37% | -12.30% |
| 04-30 | Akili, Inc. Plans to Continue to Pursue Marketing Authorization from the U.S. Food and Drug Administration for Its EndeavorOTC Product | CI |
| 04-30 | Akili, Inc. to Reduce Workforce | CI |
On December 19, 2023, Kenneth Ehlert resigned from his position as a member of the board of directors of Akili, Inc. and as a member of the Audit Committee and Nominating and Corporate Governance Committee of the Board, effective immediately. With Mr. Ehlert?s resignation, the Board no longer has a majority of ?independent directors? .
The Board now has three independent directors and three non-independent directors.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.30% | 33.58M | |
| +11.73% | 226B | |
| +9.53% | 188B | |
| +14.63% | 137B | |
| +27.47% | 108B | |
| -0.04% | 63.19B | |
| +13.73% | 52.26B | |
| +4.86% | 51B | |
| +7.72% | 43.89B | |
| +7.86% | 38.07B |
AKILI, INC. 
